TLR-4 is a key immunological pathway activated by bacterial lipopolysaccharides that produce pro-inflammatory cytokines, inducing metabolic disorders and promoting greater liver damage in patients with NAFLD (43, 44). This evidence concerns the gene TLR4 and metabolic disease.